Monday, June 27, 2011

Takeda venture arm invests in Redwood Bioscience

The venture arm of Japan’s Takeda Pharmaceutical Co. Ltd. will fund further development of a protein-modification technology from Redwood Bioscience Inc.
Redwood, of Burlingame, said the undisclosed amount from Takeda Ventures Inc. will be used to forward the company’s protein-chemical engineering technology, which could be used to better deliver drugs with better potency.

No comments:

Post a Comment